MaxCyte’s Flow Electroporation® technology and ExPERT® platform enable leading biopharmas to accelerate & streamline the drug development process. MaxCyte licenses have been granted to 100+ cell therapy programmes with 70+ licensed for clinical use. More at www.maxcyte.com